1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Europe Cell Line Development Serum Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Europe Cell Line Development Serum Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Europe Cell Line Development Serum Market Regional Analysis
6.2 Europe Cell Line Development Serum Market Revenue 2017-2027 (US$ Million)
6.3 Europe Cell Line Development Serum Market Forecast Analysis
7. Europe Cell Line Development Serum Market Analysis – by Type
7.1 Fetal Bovine Serum
- 7.1.1 Overview
- 7.1.2 Fetal Bovine Serum: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Adult Bovine Serum
- 7.2.1 Overview
- 7.2.2 Adult Bovine Serum: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Porcine Serum
- 7.3.1 Overview
- 7.3.2 Porcine Serum: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Horse Serum
- 7.4.1 Overview
- 7.4.2 Horse Serum: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Other Animal Serum
- 7.5.1 Overview
- 7.5.2 Other Animal Serum: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Europe Cell Line Development Serum Market Analysis – by Application
8.1 Bioproduction
- 8.1.1 Overview
- 8.1.2 Bioproduction: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Drug Discovery
- 8.2.1 Overview
- 8.2.2 Drug Discovery: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Tissue Engineering and Regenerative Medicines
- 8.3.1 Overview
- 8.3.2 Tissue Engineering and Regenerative Medicines: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Toxicity Testing
- 8.4.1 Overview
- 8.4.2 Toxicity Testing: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Academic Research
- 8.5.1 Overview
- 8.5.2 Academic Research: Europe Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Europe Cell Line Development Serum Market – Europe Analysis
9.1 Overview
9.2 Europe
- 9.2.1 Europe Cell Line Development Serum Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Europe Cell Line Development Serum Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 UK:
Europe Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 UK: Europe Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.1.2 UK: Europe Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.2 Germany:
Europe Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Germany: Europe Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.2.2 Germany: Europe Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.3 France:
Europe Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 France: Europe Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.3.2 France: Europe Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.4 Russia:
Europe Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Russia: Europe Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.4.2 Russia: Europe Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.5 Italy:
Europe Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Italy: Europe Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.5.2 Italy: Europe Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.6 Rest of Europe:
Europe Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.6.1 Rest of Europe: Europe Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.6.2 Rest of Europe: Europe Cell Line Development Serum Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Lonza
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sigma-Aldrich Corporation (Merck KGaA)
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Cytiva (Danaher)
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Corning Incorporated
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 European Collection of Cell Cultures (ECACC)
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 WuXi AppTec
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 American Type Culture Collection (ATCC)
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations